Novocure

Youtube Subscribe

Open: 13.43 Close: 13.3 Change: -0.13

Stop reading the whole internet to decide if you want to invest in Novocure Company Inc Stock.

This document will help you to evaluate Novocure without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novocure are: NVCR, Novocure, company, share, NovoCure, Ltd, news, and the …

Concept Map

Semantic Network

Stock Summary

NovoCure Limited engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices. The company was incorporated in 2000 and is headquartered in Saint Helier, Jersey..

Today's Summary

NovoCure Ltd (NVCR) news, articles, events & latest updates. Today Market Cap $1.42B Volume (M) 745,238.00 52-Wk High $120.03 52-wk Low $10.87 ST Data Watchers New Watcher Rank About Feed. Novocure is laying off about 200 people, 13% of its workforce, the company announced Tuesday. The company is prioritizing readiness to launch the treatment for metastatic non-small cell lung cancer. Novocure Limited (NVCR) reported earnings of -$0.46 per share, beating the Zacks Consensus Estimate of $-0.52 per share. The phase 3 trial (called LUNAR) tested a wearable TTFields device developed by the oncology biotech firm.

Today's News

NovoCure Ltd (NVCR) news, articles, events & latest updates. Today Market Cap $1.42B Volume (M) 745,238.00 52-Wk High $120.03 52-wk Low $10.87 ST Data Watchers New Watcher Rank About Feed. Novocure is laying off about 200 people, 13% of its workforce, the company announced Tuesday. The company is prioritizing readiness to launch the treatment for metastatic non-small cell lung cancer. Novocure Limited (NVCR) reported earnings of -$0.46 per share, beating the Zacks Consensus Estimate of $-0.52 per share. The phase 3 trial (called LUNAR) tested a wearable TTFields device developed by the oncology biotech firm.

Stock Profile

"NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. The company was incorporated in 2000 and is headquartered in Saint Helier, Jersey."

Keywords

The game is changing. There is a new strategy to evaluate Novocure fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novocure are: NVCR, Novocure, company, share, NovoCure, Ltd, news, and the most common words in the summary are: novocure, bloomberg, price, zacks, nvcr, report, news, . One of the sentences in the summary was: NovoCure Ltd (NVCR) news, articles, events & latest updates. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #novocure #bloomberg #price #zacks #nvcr #report #news.

Read more →

Youtube Subscribe

---